Clinical Trials in Arizona

Showing 7601-7620 of 12,706 trials

Renal Mass Registry

NCT01887574

Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.

Renal Cell Carcinoma

Mayo Clinic141 participantsStarted Jun 2013

Scottsdale, Arizona, United States

TERMINATED31 miles

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

NCT03774784

The purpose of this study is to characterize the natural history of leukocyte chemotactic factor 2 amyloidotic (ALECT2) disease. In this observational study participants with ALECT2 disease will be enrolled. Participants, who have already reached end-stage renal disease (ESRD), will provide retrospective chart review data and biological specimens at baseline only. Other participants, in addition to retrospective chart review, will be followed prospectively.

AmyloidosisLeukocyte Chemotactic Factor 2 Amyloidosis

Alnylam Pharmaceuticals26 participantsStarted Jan 2019

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Denver, Colorado, United States +28 more locations

Renal Mass Registry

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Find Trials by Condition in Arizona

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

GSK2982772 Study in Subjects With Ulcerative Colitis

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

A Gene Therapy Study for Hemophilia B

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia